| 110271-1G |
|
74974-14-4 |
(R)-2,2'-Bis-[(N,N'-diphenylphosphino)-amino]-1,1'-binaphthyl
≥98%,99%e.e.
|
1G |
C44H34N2P2 |
|
|
|
| 110271-100MG |
|
74974-14-4 |
(R)-2,2'-Bis-[(N,N'-diphenylphosphino)-amino]-1,1'-binaphthyl
≥98%,99%e.e.
|
100MG |
C44H34N2P2 |
|
|
|
| 136075-500MG |
|
1093238-03-9 |
N-[(1S)-2'-Amino-3,3'-dibromo-4,4',6,6'-tetrakis(trifluoromethyl)[1,1'-biphenyl]-2-yl]-P,P-diphenylphosphinous Amide
≥98%,-
|
500MG |
C28H15Br2F12N2P |
|
|
|
| 136075-100MG |
|
1093238-03-9 |
N-[(1S)-2'-Amino-3,3'-dibromo-4,4',6,6'-tetrakis(trifluoromethyl)[1,1'-biphenyl]-2-yl]-P,P-diphenylphosphinous Amide
≥98%,-
|
100MG |
C28H15Br2F12N2P |
|
|
|
| 136076-500MG |
|
1161404-71-2 |
N-[(1R)-2'-Amino-3,3'-dibromo-4,4',6,6'-tetrakis(trifluoromethyl)[1,1'-biphenyl]-2-yl]-P,P-diphenylphosphinous Amide
≥98%,99%e.e.
|
500MG |
C28H15Br2F12N2P |
|
|
|
| 136076-100MG |
|
1161404-71-2 |
N-[(1R)-2'-Amino-3,3'-dibromo-4,4',6,6'-tetrakis(trifluoromethyl)[1,1'-biphenyl]-2-yl]-P,P-diphenylphosphinous Amide
≥98%,99%e.e.
|
100MG |
C28H15Br2F12N2P |
|
|
|
| 136073-500MG |
|
1093238-10-8 |
N-[(1S)-2'-Amino-4,4',6,6'-tetrakis(trifluoromethyl)[1,1'-biphenyl]-2-yl]-P,P-diphenylphosphinous Amide
≥98%,99%e.e.
|
500MG |
C28H17F12N2P |
|
|
|
| 136073-100MG |
|
1093238-10-8 |
N-[(1S)-2'-Amino-4,4',6,6'-tetrakis(trifluoromethyl)[1,1'-biphenyl]-2-yl]-P,P-diphenylphosphinous Amide
≥98%,99%e.e.
|
100MG |
C28H17F12N2P |
|
|
|
| 136074-500MG |
|
1165709-81-8 |
N-[(1R)-2'-Amino-4,4',6,6'-tetrakis(trifluoromethyl)[1,1'-biphenyl]-2-yl]-P,P-diphenylphosphinous Amide
≥98%,99%e.e.
|
500MG |
C28H17F12N2P |
|
|
|
| 136074-100MG |
|
1165709-81-8 |
N-[(1R)-2'-Amino-4,4',6,6'-tetrakis(trifluoromethyl)[1,1'-biphenyl]-2-yl]-P,P-diphenylphosphinous Amide
≥98%,99%e.e.
|
100MG |
C28H17F12N2P |
|
|
|
| 134967-100MG |
|
1195511-56-8 |
[(1,2,5,6-η)-1,5-Cyclooctadiene][(4S)-2-[(5R)-6-(diphenylphosphino-κP)spiro[4.4]nona-1,6-dien-1-yl]-4,5-dihydro-4-(phenylmethyl)oxazole-κN3]-(+)Iridium(I) Tetrakis[3,5-bis(trifluoromethyl)phenyl]borate
≥98%,99%e.e.
|
100MG |
C39H42IrNOP . C32H12BF24 |
|
|
|
| 134967-25MG |
|
1195511-56-8 |
[(1,2,5,6-η)-1,5-Cyclooctadiene][(4S)-2-[(5R)-6-(diphenylphosphino-κP)spiro[4.4]nona-1,6-dien-1-yl]-4,5-dihydro-4-(phenylmethyl)oxazole-κN3]-(+)Iridium(I) Tetrakis[3,5-bis(trifluoromethyl)phenyl]borate
≥98%,99%e.e.
|
25MG |
C39H42IrNOP . C32H12BF24 |
|
|
|
| 134966-100MG |
|
1194050-19-5 |
[(1,2,5,6-η)-1,5-Cyclooctadiene][(4S)-2-[(5S)-6-(diphenylphosphino-κP)spiro[4.4]nona-1,6-dien-1-yl]-4,5-dihydro-4-(phenylmethyl)oxazole-κN3]-(+)Iridium(I) Tetrakis[3,5-bis(trifluoromethyl)phenyl]borate
≥98%,-
|
100MG |
C39H42IrNOP . C32H12BF24 |
|
|
|
| 134966-25MG |
|
1194050-19-5 |
[(1,2,5,6-η)-1,5-Cyclooctadiene][(4S)-2-[(5S)-6-(diphenylphosphino-κP)spiro[4.4]nona-1,6-dien-1-yl]-4,5-dihydro-4-(phenylmethyl)oxazole-κN3]-(+)Iridium(I) Tetrakis[3,5-bis(trifluoromethyl)phenyl]borate
≥98%,-
|
25MG |
C39H42IrNOP . C32H12BF24 |
|
|
|
| 134963-100MG |
|
1195511-59-1 |
[(1,2,5,6-η)-1,5-Cyclooctadiene][(4S)-2-[(5R)-6-(diphenylphosphino-κP)spiro[4.4]nona-1,6-dien-1-yl]-4,5-dihydro-4-phenyloxazole-κN3]-(-)-Iridium(I) Tetrakis[3,5-bis(trifluoromethyl)phenyl]borate
≥98%,-
|
100MG |
C38H40IrNOP . C32H12BF24 |
|
|
|
| 134963-25MG |
|
1195511-59-1 |
[(1,2,5,6-η)-1,5-Cyclooctadiene][(4S)-2-[(5R)-6-(diphenylphosphino-κP)spiro[4.4]nona-1,6-dien-1-yl]-4,5-dihydro-4-phenyloxazole-κN3]-(-)-Iridium(I) Tetrakis[3,5-bis(trifluoromethyl)phenyl]borate
≥98%,-
|
25MG |
C38H40IrNOP . C32H12BF24 |
|
|
|
| 134962-100MG |
|
1194050-21-9 |
[(1,2,5,6-η)-1,5-Cyclooctadiene][(4S)-2-[(5S)-6-(diphenylphosphino-κP)spiro[4.4]nona-1,6-dien-1-yl]-4,5-dihydro-4-phenyloxazole-κN3]-(+)-Iridium(I) Tetrakis[3,5-bis(trifluoromethyl)phenyl]borate
≥98%,99%e.e.
|
100MG |
C38H40IrNOP . C32H12BF24 |
|
|
|
| 134962-25MG |
|
1194050-21-9 |
[(1,2,5,6-η)-1,5-Cyclooctadiene][(4S)-2-[(5S)-6-(diphenylphosphino-κP)spiro[4.4]nona-1,6-dien-1-yl]-4,5-dihydro-4-phenyloxazole-κN3]-(+)-Iridium(I) Tetrakis[3,5-bis(trifluoromethyl)phenyl]borate
≥98%,99%e.e.
|
25MG |
C38H40IrNOP . C32H12BF24 |
|
|
|
| 134965-100MG |
|
1195511-66-0 |
[(1,2,5,6-η)-1,5-Cyclooctadiene][(4S)-2-[(5R)-6-(diphenylphosphino-κP)spiro[4.4]nona-1,6-dien-1-yl]-4,5-dihydro-4-(1-methylethyl)oxazole-κN3]-(+)-Iridium(I) Tetrakis[3,5-bis(trifluoromethyl)phenyl]borate
≥98%,99%e.e.
|
100MG |
C35H42IrNOP . C32H12BF24 |
|
|
|
| 134965-25MG |
|
1195511-66-0 |
[(1,2,5,6-η)-1,5-Cyclooctadiene][(4S)-2-[(5R)-6-(diphenylphosphino-κP)spiro[4.4]nona-1,6-dien-1-yl]-4,5-dihydro-4-(1-methylethyl)oxazole-κN3]-(+)-Iridium(I) Tetrakis[3,5-bis(trifluoromethyl)phenyl]borate
≥98%,99%e.e.
|
25MG |
C35H42IrNOP . C32H12BF24 |
|
|
|
